FARINA, LUCIA

FARINA, LUCIA  

DIPARTIMENTO DI SCIENZE MEDICHE (attivo dal 01/01/2000 al 27/04/2012)  

Mostra records
Risultati 1 - 20 di 42 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Dose-Adjusted Epoch and Rituximab for the treatment of double expressor and double hit diffuse large B-cell lymphoma: impact of TP53 mutations on clinical outcome 2021 Guidetti, AnnaPennisi, MartinaFarina, LuciaCorradini, Paolo + Article (author) -
Lamivudine prophylaxis prevents hepatitis B virus reactivation in anti-HBc positive patients under rituximab for non-Hodgkin lymphoma 2018 Loglio, AlessandroViganò, MauroFarina, LuciaRumi, MariagraziaCorradini, PaoloFacchetti, FlorianaBaldini, LucaLampertico, Pietro + Article (author) -
Predicting failure of hematopoietic stem cell mobilization before it starts : the predicted poor mobilizer (pPM) score 2018 P. CorradiniL. Farina + Article (author) -
Allogeneic Stem Cell Transplantation for Relapsed/Refractory B-Cell Lymphomas: Results of a Multicenter Phase II Prospective Trial Including Rituximab in the Reduced Intensity Conditioning Regimen 2017 F. BarrettaA. MussettiF. OnidaL. FarinaA. RambaldiP. Corradini + Article (author) -
A rare case of atypical chronic lymphocytic leukaemia presenting as nephrotic syndrome 2017 Soldarini, MartinaFarina, LuciaBolli, Niccolo + Article (author) -
High-dose chemotherapy followed by autologous transplantation may overcome the poor prognosis of diffuse large B-cell lymphoma patients with MYC/BCL2 co-expression 2016 F. MauraA. GuidettiA. PellegrinelliM. PennisiC. CaprioliL. FarinaN. BolliCABRAS, ANTONELLO DOMENICOP. Corradini + Article (author) -
The Role of Autologous and Allogeneic Stem Cell Transplantation in Follicular Lymphoma in The New Drugs Era 2016 F. MauraL. FarinaP. Corradini Article (author) -
Phase II study of perifosine and sorafenib dual-targeted therapy in patients with relapsed or refractory lymphoproliferative diseases 2014 A. GuidettiC. Carlo-StellaL. FarinaL. GiordanoP. CorradiniA.M. Gianni + Article (author) -
Serum thymus and activation-regulated chemokine level monitoring may predict disease relapse detected by pet scan after reduced-intensity allogeneic stem cell transplantation in patients with Hodgkin lymphoma 2014 L. FarinaREZZONICO, FRANCESCAF. SpinaDALTO, SERENA CAMILLAP. Corradini + Article (author) -
Peripheral blood CD34+ cell monitoring after cyclophosphamide and granulocyte-colony-stimulating factor : an algorithm for the pre-emptive use of plerixafor 2014 L. FarinaF. SpinaA. GuidettiC. Carlo-StellaP. Corradini + Article (author) -
Long-term molecular remission with lenalidomide treatment of relapsed chronic lymphocytic leukemia 2013 F. SpinaF. RezzonicoL. FarinaP. Corradini Article (author) -
Current state of art for transplantation paradigms in peripheral T-cell lymphomas 2013 L. FarinaP. Corradini + Article (author) -
Allogeneic transplantation for Hodgkin's lymphoma 2011 P. CorradiniL. Farina + Article (author) -
Allogeneic transplantation for lymphoma : long-term outcome 2010 P. CorradiniL. Farina Article (author) -
The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation 2009 L. FarinaF. SpinaMORELLI, MARAP. Corradini + Article (author) -
Qualitative and quantitative polymerase chain reaction monitoring of minimal residual disease in relapsed chronic lymphocytic leukemia : early assessment can predict long-term outcome after reduced intensity allogeneic transplantation 2009 L. FarinaA. VendraminA. RaganatoF. SpinaP. Corradini + Article (author) -
Haploidentical stem cell transplantation after a reduced-intensity conditioning regimen for the treatment of advanced hematologic malignancies : posttransplantation CD8-depleted donor lymphocyte infusions contribute to improve T-cell recovery 2009 RAGANATO, ANNAA. VendraminL. FarinaF. SpinaC. Carlo StellaP. Corradini + Article (author) -
Reduced-intensity allogeneic stem cell transplantation using related haploidentical donors for relapsed or refractory lymphomas : evidence of anti-tumour activity in poor prognosis disease 2008 P. CorradiniA. RaganatoL. Farina + Article (author) -
The hematopoietic cell transplantation-specific comorbidity index (HCT-CI) predicts survival and non-relapse mortality in lymphoma and myeloma patients receiving a RIC allograft 2008 L. FarinaP. Corradini + Article (author) -
The hematopoietic cell transplantation-specific comorbidity index (HCT-CI) predicts survival and non-relapse mortality in lymphoma and myeloma patients receiving a RIC allograft 2008 L. FarinaP. Corradini + Article (author) -